To examine whether the initial serum TIMP-1 levels were a useful biomarker for predicting the prognosis of motor neuropathy in MPA, we evaluated the correlations between the initial serum TIMP-1 levels and CMAP amplitudes after immunosuppressive therapy (Supplementary Figure S2A–H). Here, TIMP1 is linked to microscopic polyangiitis.